Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13081
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSimmonds, Pen
dc.contributor.authorSilberstein, Men
dc.contributor.authorMcKendrick, Jen
dc.date.accessioned2015-05-16T02:51:41Z
dc.date.available2015-05-16T02:51:41Z
dc.date.issued1993-06-01en
dc.identifier.citationAustralian and New Zealand Journal of Medicine; 23(3): 264-7en
dc.identifier.govdoc7688954en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/13081en
dc.description.abstractThe accuracy of the assessment of patients with malignant disease and of their response to chemotherapy has been significantly improved with the routine availability of computerized tomography (CT) scanning. CT abnormalities, however, may be non-specific, especially after chemotherapy. Rebound enlargement of the thymus gland after chemotherapy induced atrophy is one cause of an abnormal thoracic CT scan on re-staging.This phenomenon has previously been reported mainly in relation to the treatment of lymphoma and germ cell cancers. This paper highlights the occurrence of thymic hyperplasia after chemotherapy in these and other tumour types.We discuss five cases including three patients with malignancies other than lymphoma in whom thymus enlargement occurred during or after intensive chemotherapy.Clear identification of the nature of CT abnormalities after chemotherapy, particularly in the mediastinum, is required prior to embarking on further anti-cancer treatments.en
dc.language.isoenen
dc.subject.otherAdulten
dc.subject.otherAntineoplastic Combined Chemotherapy Protocols.adverse effects.therapeutic useen
dc.subject.otherBleomycin.administration & dosageen
dc.subject.otherDacarbazine.administration & dosageen
dc.subject.otherDoxorubicin.administration & dosageen
dc.subject.otherHodgkin Disease.drug therapyen
dc.subject.otherHumansen
dc.subject.otherMaleen
dc.subject.otherMechlorethamine.administration & dosageen
dc.subject.otherPrednisone.administration & dosageen
dc.subject.otherProcarbazine.administration & dosageen
dc.subject.otherThymus Hyperplasia.chemically induced.radiographyen
dc.subject.otherTomography, X-Ray Computeden
dc.subject.otherVinblastine.administration & dosageen
dc.subject.otherVincristine.administration & dosageen
dc.titleThymic hyperplasia in adults following chemotherapy for malignancy.en
dc.typeJournal Articleen
dc.identifier.journaltitleAustralian and New Zealand Journal of Medicineen
dc.identifier.affiliationLudwig Institute Oncology Unit, Austin Hospital, Melbourne, Victoria, Australiaen
dc.description.pages264-7en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/7688954en
dc.type.austinJournal Articleen
item.languageiso639-1en-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

8
checked on May 10, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.